372 related articles for article (PubMed ID: 26145760)
21. Rsf-1 expression in rectal cancer: with special emphasis on the independent prognostic value after neoadjuvant chemoradiation.
Lin CY; Tian YF; Wu LC; Chen LT; Lin LC; Hsing CH; Lee SW; Sheu MJ; Lee HH; Wang YH; Shiue YL; Wu WR; Huang HY; Hsu HP; Li CF; Chen SH
J Clin Pathol; 2012 Aug; 65(8):687-92. PubMed ID: 22569540
[TBL] [Abstract][Full Text] [Related]
22. Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial.
Chua YJ; Barbachano Y; Cunningham D; Oates JR; Brown G; Wotherspoon A; Tait D; Massey A; Tebbutt NC; Chau I
Lancet Oncol; 2010 Mar; 11(3):241-8. PubMed ID: 20106720
[TBL] [Abstract][Full Text] [Related]
23. Molecular markers predict distant metastases after adjuvant chemoradiation for rectal cancer.
Kim JW; Kim YB; Choi JJ; Koom WS; Kim H; Kim NK; Ahn JB; Lee I; Cho JH; Keum KC
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):e577-84. PubMed ID: 22981710
[TBL] [Abstract][Full Text] [Related]
24. Low molecular weight heat shock protein HSP27 is a prognostic indicator in rectal cancer but not colon cancer.
Tweedle EM; Khattak I; Ang CW; Nedjadi T; Jenkins R; Park BK; Kalirai H; Dodson A; Azadeh B; Terlizzo M; Grabsch H; Mueller W; Myint S; Clark P; Wong H; Greenhalf W; Neoptolemos JP; Rooney PS; Costello E
Gut; 2010 Nov; 59(11):1501-10. PubMed ID: 20947885
[TBL] [Abstract][Full Text] [Related]
25. Incidence of chemotherapy- and chemoradiotherapy-induced amenorrhea in premenopausal women with stage II/III colorectal cancer.
Wan J; Gai Y; Li G; Tao Z; Zhang Z
Clin Colorectal Cancer; 2015 Mar; 14(1):31-4. PubMed ID: 25446053
[TBL] [Abstract][Full Text] [Related]
26. Colorectal cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas.
Li M; Li JY; Zhao AL; Gu J
Oncology; 2007; 73(1-2):52-7. PubMed ID: 18334831
[TBL] [Abstract][Full Text] [Related]
27. Robotic versus open total mesorectal excision for rectal cancer: comparative study of short and long-term outcomes.
Ghezzi TL; Luca F; Valvo M; Corleta OC; Zuccaro M; Cenciarelli S; Biffi R
Eur J Surg Oncol; 2014 Sep; 40(9):1072-9. PubMed ID: 24646748
[TBL] [Abstract][Full Text] [Related]
28. Should rectal cancer located 10-15 cm from the anal verge be defined as colon cancer.
Swets M; Breugom AJ; Gelderblom H; van de Velde CJH
Ann Oncol; 2017 Mar; 28(3):664-665. PubMed ID: 27836884
[No Abstract] [Full Text] [Related]
29. Pharmacogenetic study in rectal cancer patients treated with preoperative chemoradiotherapy: polymorphisms in thymidylate synthase, epidermal growth factor receptor, GSTP1, and DNA repair genes.
Páez D; Salazar J; Paré L; Pertriz L; Targarona E; del Rio E; Barnadas A; Marcuello E; Baiget M
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1319-27. PubMed ID: 21570215
[TBL] [Abstract][Full Text] [Related]
30. Intramural and mesorectal distal spread detected by whole-mount sections in the determination of optimal distal resection margin in patients undergoing surgery for rectosigmoid or rectal cancer without preoperative therapy.
Shimada Y; Takii Y; Maruyama S; Ohta T
Dis Colon Rectum; 2011 Dec; 54(12):1510-20. PubMed ID: 22067179
[TBL] [Abstract][Full Text] [Related]
31. New approaches to assessing and treating early-stage colon and rectal cancers: cooperative group strategies for assessing optimal approaches in early-stage disease.
Benson AB
Clin Cancer Res; 2007 Nov; 13(22 Pt 2):6913s-20s. PubMed ID: 18006800
[TBL] [Abstract][Full Text] [Related]
32. PIK3CA mutations predict local recurrences in rectal cancer patients.
He Y; Van't Veer LJ; Mikolajewska-Hanclich I; van Velthuysen ML; Zeestraten EC; Nagtegaal ID; van de Velde CJ; Marijnen CA
Clin Cancer Res; 2009 Nov; 15(22):6956-62. PubMed ID: 19903786
[TBL] [Abstract][Full Text] [Related]
33. Improved outcomes for rectal cancer in the era of preoperative chemoradiation and tailored mesorectal excision: a series of 338 consecutive cases.
Pacelli F; Sanchez AM; Covino M; Tortorelli AP; Bossola M; Valentini V; Gambacorta MA; Doglietto GB
Am Surg; 2013 Feb; 79(2):151-61. PubMed ID: 23336654
[TBL] [Abstract][Full Text] [Related]
34. Neo-adjuvant chemoradiotherapy and multivisceral resection to optimize R0 resection of locally recurrent adherent colon cancer.
Hallet J; Zih FS; Lemke M; Milot L; Smith AJ; Wong CS
Eur J Surg Oncol; 2014 Jun; 40(6):706-12. PubMed ID: 24534363
[TBL] [Abstract][Full Text] [Related]
35. Outcomes in locally advanced rectal cancer with highly selective preoperative chemoradiotherapy.
Williamson JS; Jones HG; Davies M; Evans MD; Hatcher O; Beynon J; Harris DA;
Br J Surg; 2014 Sep; 101(10):1290-8. PubMed ID: 24924947
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of oncogenesis in colon versus rectal cancer.
Kapiteijn E; Liefers GJ; Los LC; Kranenbarg EK; Hermans J; Tollenaar RA; Moriya Y; van de Velde CJ; van Krieken JH
J Pathol; 2001 Sep; 195(2):171-8. PubMed ID: 11592095
[TBL] [Abstract][Full Text] [Related]
37. The differential impact of microsatellite instability as a marker of prognosis and tumour response between colon cancer and rectal cancer.
Hong SP; Min BS; Kim TI; Cheon JH; Kim NK; Kim H; Kim WH
Eur J Cancer; 2012 May; 48(8):1235-43. PubMed ID: 22071131
[TBL] [Abstract][Full Text] [Related]
38. Rectal cancer: current surgical management.
Zolfaghari S; Williams LJ; Moloo H; Boushey RP
Minerva Chir; 2010 Apr; 65(2):197-211. PubMed ID: 20548275
[TBL] [Abstract][Full Text] [Related]
39. Current controversies in colon and rectal cancer.
Vo DM; Julien LA; Thorson AG
Minerva Chir; 2010 Dec; 65(6):677-93. PubMed ID: 21224801
[TBL] [Abstract][Full Text] [Related]
40. Survival outcome of local excision versus radical resection of colon or rectal carcinoma: a Surveillance, Epidemiology, and End Results (SEER) population-based study.
Bhangu A; Brown G; Nicholls RJ; Wong J; Darzi A; Tekkis P
Ann Surg; 2013 Oct; 258(4):563-9; discussion 569-71. PubMed ID: 23979270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
